Business Information
The group's principal activities are to design and execute customized sales and marketing campaigns for pharmaceutical, biotech and medical devices and diagnostics industries. The group operates in three segments namely: sales and marketing services, pharmaceutical products and medical devices and diagnostics. Sales and marketing services segment designs and implements product promotion programs for pharmaceutical companies. The pharmaceutical product segment sources pharmaceutical products through licensing, copromotion and acquisition arrangements. The medical devices and diagnostics segment offers sales and marketing activities to the pharmaceutical industry. The customers of the group include astrazeneca, novartis, glaxosmithkline, aventis, pfizer and pharmacia.
|
|
Name |
Title
|
Email
|
| John Dugan | Founder, Chmn., Dir. - Strategic Planning | N/A | | Michael Marquard | CEO | N/A | | David Stievater | Sr. VP - Emerging Pharma | N/A | | Jeffrey Smith | Exec. VP, CFO, Treasurer | N/A | | Jo Ann Saitta | Sr. VP - Information Technology | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 239,242 | 11,809 | | 2005 | 319,415 | (19,454) | | 2004 | 364,444 | 21,132
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
